Skip to main content
Livermore
Livermore
ZHEN

State Street Corp

SEC CIK
0000093751
Latest filing
Sep 22, 2026

SAGE holding history

Sage Therapeutics, Inc. in every 13F filed by State Street Corp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SAGE overviewAll 13F holders of SAGEFull Q2 2026 holdings

Shares (Q3 2025)
0
Sold out in Q3 2025
Value
$0
% of portfolio
0.0%
Quarters held
18
Since Q1 2021
Holdings of SAGE by State Street Corp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 20250$00.0%−1,166,002−100.0%Sold outHolders
Q2 20251,166,002$10.6M<0.1%−22,572−1.9%ReducedHolders
Q1 20251,188,574$9.45M<0.1%−84,076−6.6%ReducedHolders
Q4 20241,272,650$6.91M<0.1%−1,653,589−56.5%ReducedHolders
Q3 20242,926,239$21.1M<0.1%+451,377+18.2%AddedHolders
Q2 20242,474,862$26.9M<0.1%−2,019,934−44.9%ReducedHolders
Q1 20244,494,796$84.2M<0.1%+576,574+14.7%AddedHolders
Q4 20233,918,222$84.9M<0.1%−460,245−10.5%ReducedHolders
Q3 20234,378,467$90.1M<0.1%+2,079,327+90.4%AddedHolders
Q2 20232,299,140$108.1M<0.1%−435,233−15.9%ReducedHolders
Q1 20232,734,373$114.7M<0.1%+7,077+0.3%AddedHolders
Q4 20222,727,296$104.0M<0.1%−227,387−7.7%ReducedHolders
Q3 20222,954,683$115.7M<0.1%+20,619+0.7%AddedHolders
Q2 20222,934,064$94.8M<0.1%+98,708+3.5%AddedHolders
Q1 20222,835,356$93.8M<0.1%+666,826+30.8%AddedHolders
Q4 20212,168,530$92.2M<0.1%+192,578+9.7%AddedHolders
Q3 20211,975,952$87.6M<0.1%+639,194+47.8%AddedHolders
Q2 20211,336,758$75.9M<0.1%+79,368+6.3%AddedHolders
Q1 20211,257,390$94.1M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.